Bausch Health Companies Inc. (BHC, BHC.TO) said the company and certain of its affiliates have entered into a definitive agreement to sell all of their equity interests in Amoun Pharmaceutical Company S.A.E. to Abu-Dhabi based ADQ, for total gross consideration of approximately $740 million.

Create Account

Dark

chart

exchange

Check out our Level2View

Bausch Health Companies Inc. (BHC, BHC.TO) said the company and certain of its affiliates have entered into a definitive agreement to sell all of their equity interests in Amoun Pharmaceutical Company S.A.E. to Abu-Dhabi based ADQ, for total gross consideration of approximately $740 million.

RTTNews | Mar 31, 2021 08:18AM EDT

08:17 Wednesday, March 31, 2021 (RTTNews.com) - Bausch Health Companies Inc. (BHC, BHC.TO) said the company and certain of its affiliates have entered into a definitive agreement to sell all of their equity interests in Amoun Pharmaceutical Company S.A.E. to Abu-Dhabi based ADQ, for total gross consideration of approximately $740 million.

"The sale of Amoun marks significant progress in our efforts to reduce overall Bausch Health debt as we continue to pursue all opportunities to drive value for our shareholders, including preparing for the spinoff of Bausch + Lomb," said Joseph Papa, chairman and CEO, Bausch Health.

Read the original article on RTTNews ( https://www.rttnews.com/3181701/bausch-health-enters-deal-to-sell-equity-interests-in-amoun-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved